- Home
- Jeffrey Weitz
Jeffrey Weitz
Thrombosis and Atherosclerosis Research Institute (TaARI), Hamilton, CA
Biography
Prof Jeffrey I Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton, CA.
He is Past President of the International Society on Thrombosis and Haemostasis and board certified in internal medicine, haematology and medical oncology. Dr Weitz specialises in the care of patients with thrombotic disorders.
His internationally recognised research spans the biochemistry of blood coagulation and fibrinolysis, preclinical thrombosis models and clinical trials of antithrombotic therapies. He has authored over 650 publications across journals such as Blood, Circulation, Lancet, New England Journal of Medicine, Journal of Clinical Investigation and Annals of Internal Medicine, as well as 76 book chapters.
Prof Weitz is an Officer of the Order of Canada and a Fellow of the American Heart Association, the Royal Society of Canada and the Canadian Academy of Health Sciences.
Featured Courses
- 1.00
Published:
Learning objectives
- Discuss the unmet needs in thrombosis management, MACE burden after ACS, stroke in AF and secondary stroke prevalence and consequences
- Evaluate the current standard of care for the treatment of ACS, SSP and AF and its limitations
- Review guidelines and critique current prescribing practices and the implications of inadequate treatment
- Explain the different strategies for targeting FXI and how FXI inhibition mechanisms differentiate from traditional anticoagulation therapies
- Identify emerging anticoagulant strategies and describe the efficacy and safety data from Phase 2 FXI inhibitor clinical trials as well as ongoing Phase 3 trials and potential place in therapy for ACS, AF and SSP
- Apply evidence-based anticoagulation strategies by optimising treatment decisions and addressing patient-specific risk factors